Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,821 public trials 2,099 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Not Yet Recruiting

An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy

NCT07631871

Conditions: Adnexal Diseases, CERVICAL NEOPLASMS, Carcinoma, +38 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

CLINICAL STUDY TO IDENTIFY BIOMARKERS FOR TUMOR SPREAD THROUGH AIR SPACES STATUS

NCT07630246

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations: NMS Research | Cancer Nanomedicine - João Conde's Lab Lisbon, Portugal

Unidade Local de Saúde de São José Lisbon, Portugal

View Trial Details

Not Yet Recruiting

Liver Transplant for Hepatocellular Carcinoma

NCT07629193

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

NCT07625527

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +14 more
Locations: The Second Hospital of Tianjin Medical University Tianjin, China

General Hospital of Tianjin Medical University Tianjin, China

Tianjin Hospital Tianjin, China

Xingtai People's Hospital Xingtai, China

View Trial Details

Not Yet Recruiting

Anlotinib + Benmelstobart vs Surgery for Patients With Localized Renal Cell Carcinoma Scheduled to Undergo Partial Nephrectomy

NCT07627464

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Peking University Third Hospital Beijing, China

Jilin Provincial Cancer Hospital Changchun, China

Hunan Provincial Cancer Hospital Changsha, China

The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China

View all 14 locations

View Trial Details

Not Yet Recruiting

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

NCT07619313

Conditions: Adenocarcinoma, Borderline Resectable Pancreatic Ductal Adenocarcinoma, Carcinoma, +18 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal Cancer Followed by De-Intensified Radiation Compared With Standard Chemoradiation

NCT07628062

Conditions: Carcinoma, Carcinoma, Squamous Cell, HPV-positive Oropharyngeal Squamous Cell Carcinoma, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes

NCT07557914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: The First Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Not Yet Recruiting

A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors

NCT07623369

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +69 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors

NCT07090070

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
Locations: Vancouver General Hospital Vancouver, British Columbia, Canada

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions